This article is based on a composite of talks presented during the Double Jeopardy: Prematurity and Congenital Heart Disease Plenary Session at NeoHeart 2020, a global virtual conference.
Prematurity and low weight remain significant risk factors for mortality after neonatal cardiac surgery despite a steady increase in survival. Newer and lower weight thresholds for operability are constantly generated as surgeons gather proficiency, technical mastery, and experience in performing complex procedures on extremely small infants. The relationship between birth weight and survival after cardiac surgery is nonlinear with 2 kilograms (kg) being an inflection point below which marked decline in survival occurs.
The prevalence of congenital heart disease (CHD) in premature infants is more than twice that in term born infants. Increased risk of preterm birth in infants with CHD is most commonly due to spontaneous preterm birth and remains poorly understood.
Advances in Neonatal-Perinatal medicine have led to a marked improvement in survival of neonates born prematurely over the last several decades. However, the risk of severe morbidities including retinopathy of prematurity, intraventricular hemorrhage, bronchopulmonary dysplasia and necrotizing enterocolitis remains significant in extremely low birth weight infants. Premature infants with CHD are at a greater risk of prematurity related morbidities than premature infants without CHD. Interventions that have been successful in decreasing the risk of these morbidities are addressed.
TannerKSabrineNWrenC. Cardiovascular malformations among preterm infants. Pediatrics. 2005;116(6):e833-e838.
2.
Preterm birth. Available at https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm. Accessed October 20, 2021.
3.
NebhardWNSalemiJLHauserKWKornoskyJL. Are there ethnic disparities in risk of preterm birth among infants born with congenital heart defects?Birth Defects Res A Clin Mol Teratol. 2007 Nov;79(11):754-764.
4.
JenkinsKJGauvreauK. Center-specific differences in mortality: preliminary analyses using the risk adjustment in congenital heart surgery (RACHS-1) method. Journal of Thoracic & Cardiovascular Surgery. 2002;124(1):97-104.
SteurerMABaerRJKellerRL, et al.Gestational Age and outcomes in critical congenital heart disease. Pediatrics. 2017;140(4):e20170999.
7.
MadarJRichmondSHeyE. Surfactant-deficient respiratory distress after elective delivery at ‘term’. Acta Paediatr. 1999;88(11): (CLABSI) 1244-1248.
8.
CostelloJMPolitoABrownDW, et al.Birth before 39 weeks’ gestation is associated with worse outcomes in neonates with heart disease. Pediatrics. 2010;126(2):277-284.
9.
CostelloJMPasqualiSKJacobsJP, et al.Gestational age at birth and outcomes after neonatal cardiac surgery: an analysis of the society of thoracic surgeons congenital heart surgery database. Circulation. 2014;129(24):2511-2517.
10.
CnotaJFGuptaRMichelfelderECIttenbachRF. Congenital heart disease infant death rates decrease as gestational age advances from 34 to 40 weeks. J Pediatr. 2011;159(5):761-765.
11.
YoungPCGlasgowTSLiXGuest-WarnickGStoddardG. Mortality of late-preterm (near-term) newborns in utah. Pediatrics. 2007;119(3):e659-e665.
12.
GoffDALuanXGerdesM, et al.Younger gestational age is associated with worse neurodevelopmental outcomes after cardiac surgery in infancy. J Thorac Cardiovasc Surg. 2012;143(3):535-542.
13.
CalderonJStoppCWypijD, et al.Early-Term birth in single-ventricle congenital heart disease after the fontan procedure: neurodevelopmental and psychiatric outcomes. J Pediatr. 2016;179: 96-103.
14.
DonofrioMTMoon-GradyAJHornbergerLK, et al.American Heart association adults With congenital heart disease joint committee of the council on cardiovascular disease in the Y, council on clinical cardiology CoCS, anesthesia, council on C and stroke N. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American heart association. Circulation. 2014;129(21):2183-2242.
15.
AugerNFraserWDHealey-ProfitosJ, et al.Association between preeclampsia and congenital heart defects. JAMA.2015;314(15):1588-1598.
16.
CurzonCLMilford-BelandSLiJS, et al.Cardiac surgery in infants with low birth weight is associated with increased mortality: analysis of the society of thoracic surgeons congenital heart database. J Thorac Cardiovasc Surg. 2008;135(3):546-551.
17.
LevyRJRosenthalAFylerDCNadasAS. Birthweight of infants with congenital heart disease. Am J Dis Child. 1978;132(3):249-254.
18.
MalikSClevesMAZhaoWCorreaAHobbsCA. Association between congenital heart defects and small for gestational age. Pediatrics. 2007;119(4):e976-e982.
19.
MillerTAGhanayemNSNewburgerJW, et al.Pediatric heart network I. Gestational Age, birth weight, and outcomes Six years after the Norwood procedure. Pediatrics. 2019;143(5):e20182577.
20.
MatthiesenNBHenriksenTBAgergaardP, et al.Congenital heart defects and indices of placental and fetal growth in a nationwide study of 924 422 liveborn infants. Circulation. 2016;134(20):1546-1556.
21.
HoDYJosowitzRKatcoffH, et al.Mid-gestational fetal placental blood flow is diminished in the fetus with congenital heart disease. Prenat Diagn. 2020;40(11):1432-1438.
22.
GaynorJWParrySMoldenhauerJS, et al.The impact of the maternal-foetal environment on outcomes of surgery for congenital heart disease in neonates. Eur J Cardiothorac Surg. 2018;54(2):348-353.
23.
SteurerMAPeyvandiSBaerRJ, et al.Impaired fetal environment and gestational Age: what Is driving mortality in neonates With critical congenital heart disease?J Am Heart Assoc. 2019;8(22):e013194.
24.
SteurerMABaerRJBurkeE, et al.Effect of fetal growth on 1-year mortality in neonates With critical congenital heart disease. J Am Heart Assoc. 2018;7(17):e009693.
25.
SteurerMAPeyvandiSCostelloJM, et al.Association between Z-score for birth weight and postoperative outcomes in neonates and infants with congenital heart disease. Circulation. 2020;142(6):1838-1847A12360.
26.
LopezKNMorrisSASexson TejtelSKEspaillatASalemiJL. US Mortality attributable to congenital heart disease across the lifespan from 1999 through 2017 exposes persistent racial/ethnic disparities. Circulation. 2020;142(12):1132-1147.
27.
DiBardinoDJPasqualiSKHirschJC, et al.Effect of sex and race on outcome in patients undergoing congenital heart surgery: an analysis of the society of thoracic surgeons congenital heart surgery database. Ann Thorac Surg. 2012;94(6):2054-2059. discussion 2059-60.
28.
OsterMEStricklandMJMahleWT. Racial and ethnic disparities in post-operative mortality following congenital heart surgery. J Pediatr. 2011;159(2):222-226.
29.
HickeyEJNosikovaYZhangH, et al.Very low-birth-weight infants with congenital cardiac lesions: is there merit in delaying intervention to permit growth and maturation?J Thorac Cardiovasc Surg. 2012;143(1):126–136 e1.
30.
KalfaDKrishnamurthyGDuchonJ, et al.Outcomes of cardiac surgery in patients weighing <2.5 Kg: effect of patient-dependent and independent variables. J Thorac Cardiovasc Surg. 2014 Dec;148(6):2499-2506.
31.
SteurerMABaerRJKellerRL, et al.Gestational age and outcomes in critical congenital heart disease. Pediatrics.2017;140(4):e20170999.
32.
BallabhP. Pathogenesis and prevention of intraventricular hemorrhage. Clin Perinatol. 2014;41(1):47-67.
33.
SchmidtBRobertsRSSaigalSWrightLL. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med.2001;344(26):1966-1972.
34.
FogartyMOsbornDAAskieL, et al.Delayed versus early umbilical cord clamping for preterm infants: a systematic review and meta-analysis. Am J Obstet Gynecol.2018;218(1):1-18.
35.
LichtDJSheraDMClancyRR, et al.Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg.2009;137(3):529-536.
36.
LichtDJWangJSilvertreDW, et al.Preoperative cerebral blood flow is diminished in neonates with severe congenital heart defects. J Thorac Cardiovasc Surg.2004;128(6):841-849.
37.
OrtinauCMAnadkatJSSmyserCD, et al.Intraventricular hemorrhage in moderate to severe congenital heart disease. Pediatr Crit Care Med.2018;19(1):56-63.
38.
PappasAShankaranSHansenNI, et al.Outcomes of extremely low birth weight infants with congenital heart defects in the eunice kennedy shriver NICHD neonatal research network. Pediatr Cardiol. 2012;33(8):1415-1426.
39.
AxelrodDMChockVYReddyVM. Management of the preterm infants with congenital heart disease. Clin Perinatol.2016;43(1):157-171.
40.
AndersonASmithPCoreyK, et al.Clinical outcomes in very low birth weight infants with major congenital heart defects. Early Hum Dev. 2014;90(12):791-795.
41.
HigginsRDJobeAHKoso-ThomasM, et al.Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr. 2018;197: 300-308.
42.
JensenESchmidtB. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100(3):145-157.
43.
AndersonPJDoyleLW. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol. 2006;30(4):227-232.
44.
TrembathALaughonM. Predictors of bronchopulmonary dysplasia. Clin Perinatol. 2012;39(3):585-601.
45.
WrightCKirpalaniH. Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Pediatrics. 2011;128(1):111-126.
46.
ShahzadTRadajewskiSChaoC, et al.Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr. 2016;3(23):1-8.
47.
ThomasWSpeerCP. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome?Neonatology.2011;99(3):177-187.
48.
AbmanSCollacoJShepherdE, et al.Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017;181:12-28.e1.
49.
AmbalavananN. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics.2005;115(3):e249-e254.
50.
SchmidtBRobertsRSDavisP, et al.Caffeine therapy for apnea of prematurity. N Engl J Med.2006;354(20):2112-2121.
51.
FischerHSBührerC. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics.2013;132(5):e1351-e1360.
52.
PolitoAPigaSCogoP, et al.Increased morbidity and mortality in very pretern/VLBW infants with congenital heart disease. Intensive Care Med. 2013;39(6):1104-1112.
53.
SongWSKimCYLeeBS, et al.Morbidity and mortality of very low birth weight infants with congenital heart disease. Korean Circ J. 2020;50(12):1113-1123.
54.
McMahonCPennyDNelsonD, et al.Preterm infants with congenital heart disease and bronchopulmonary dysplasia: postoperative course and outcome after cardiac surgery. Pediatrics. 2005;116(2):423-430.
55.
NeuJWalkerW. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255-264.
56.
MateiAMontalvaLGoodbaumALauritiGZaniA. Neurodevelopmental impairment in necrotizing enterocolitis survivors: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):432-439.
57.
BellE. Preventing necrotizing enterocolitis: what works and how safe?Pediatrics. 2005;115(1):173-174.
58.
MillerJTonkinEDamarellR, et al.A systematic review and meta-analysis of human milk feeding and morbidity in very low birth weight infants. Nutrients. 2018;10(6):707.
59.
GargBDKabraNSBansalA. Role of delayed cord clamping in prevention of necrotizing enterocolitis in preterm neonates: a systematic review. J Matern Fetal Neonatal Med.2019;32(1):164-172.
60.
OddieSJYoungLMcGuireW. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev.2017;8(8):CD001241.
61.
SharifSMeaderNOddieSRojas-ReyesMMcGuireW. Probiotics to prevent necrotizing enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst Rev. 2020;10(10):CD005496.
62.
Bin-NunABromikerRWilschanskiM, et al.Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005;147(2):192-196.
63.
LewisZShaniGMasarwehC, et al.Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res. 2016;79(3):445-452.
64.
PremakumarMHPammiMSureshG. Human milk-derived fortifier versus bovine-milk derived fortifier for prevention of mortality and morbidity in preterm neonates. Cochrane Databse Syst Rev. 2019;(11): CD013145.
65.
BeckerKCHornikCPCottonCM, et al.Necrotizing enterocolitis in infants with ductal-dependent congenital heart disease. Am J Perinatol.2015;32(7):633-638.
66.
GoodWHardyRDobsonV, et al.The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics. 2005;116(1):15-23.
67.
HartnettMPennJ. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2012;367(26):2515-2526.
68.
AskieLMDarlowBAFinerN, et al.Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration. JAMA.2018;319(21):2190-2201.
69.
SankarMJSankarJChandraP. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev.2018;1(1):CD009734.
70.
JohnsKJohnsJFemanSDoddD. Retinopathy of prematurity in infants with cyanotic congenital heart disease. Am J Dis Child. 1991;145(2):200-203.
71.
NormanMHakanssonSKusudaS, et al.Neonatal outcomes in very preterm infants with severe congenital heart defects: an international cohort study. J Am Heart Assoc. 2020;9(5):e015369.
